长期安全性-话题@MedSci

#长期安全性#

34篇内容 | 1405人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1990274, encodeId=e6e019902e486, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=J Natl Cancer Inst：HR+/HER2-乳腺癌哌柏西利联合内分泌治疗的长期安全性分析, objectType=article, longId=144861, objectId=72eb14486150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72eb14486150, replyNumber=0, likeNumber=60, createdTime=2018-12-21, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72eb14486150, moduleTitle=J Natl Cancer Inst：HR+/HER2-乳腺癌哌柏西利联合内分泌治疗的长期安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72eb14486150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990270, encodeId=98a719902e054, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性, objectType=article, longId=116645, objectId=eb9611664500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb9611664500, replyNumber=0, likeNumber=100, createdTime=2017-12-18, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb9611664500, moduleTitle=Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb9611664500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990271, encodeId=7f1d19902e1e3, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=JACC：铂铬合金依维莫司洗脱支架用于冠脉疾病的长期安全性和疗效, objectType=article, longId=123059, objectId=9eb6123059d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eb6123059d4, replyNumber=0, likeNumber=89, createdTime=2018-04-24, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eb6123059d4, moduleTitle=JACC：铂铬合金依维莫司洗脱支架用于冠脉疾病的长期安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eb6123059d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990268, encodeId=cbc619902688e, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性, objectType=article, longId=102482, objectId=fcbd10248200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcbd10248200, replyNumber=0, likeNumber=80, createdTime=2017-07-06, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcbd10248200, moduleTitle=Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcbd10248200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990267, encodeId=e1ad199026ec4, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者采用替格列汀与canagliflozin联合治疗的长期安全性和疗效！, objectType=article, longId=102438, objectId=598e102438d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=598e102438d5, replyNumber=0, likeNumber=72, createdTime=2017-09-11, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=598e102438d5, moduleTitle=Diabetes Obes Metab：2型糖尿病患者采用替格列汀与canagliflozin联合治疗的长期安全性和疗效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=598e102438d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990266, encodeId=3326199026666, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=Am J Kidney Dis：血液透析：蔗糖铁vs葡萄糖酸钠铁复合物的长期安全性, objectType=article, longId=100916, objectId=229d10091663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=229d10091663, replyNumber=0, likeNumber=0, createdTime=2018-03-26, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=229d10091663, moduleTitle=Am J Kidney Dis：血液透析：蔗糖铁vs葡萄糖酸钠铁复合物的长期安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=229d10091663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990269, encodeId=b2451990269b0, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=J Am Acad Dermatol：crisaborole（2%乳膏）治疗轻度至中度特应性皮炎患者的长期安全性研究（AD-303）, objectType=article, longId=111334, objectId=372d11133436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=372d11133436, replyNumber=0, likeNumber=59, createdTime=2018-05-26, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=372d11133436, moduleTitle=J Am Acad Dermatol：crisaborole（2%乳膏）治疗轻度至中度特应性皮炎患者的长期安全性研究（AD-303）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=372d11133436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990264, encodeId=9feb199026458, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=JACC：药物洗脱支架和金属裸支架的长期安全性, objectType=article, longId=51894, objectId=fca351894e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fca351894e3, replyNumber=0, likeNumber=79, createdTime=2016-03-01, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fca351894e3, moduleTitle=JACC：药物洗脱支架和金属裸支架的长期安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fca351894e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990265, encodeId=e78a1990265f2, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=JACC：依维莫司洗脱支架的长期安全性优于西罗莫司洗脱支架, objectType=article, longId=63339, objectId=8a316333963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a316333963, replyNumber=0, likeNumber=60, createdTime=2016-07-06, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a316333963, moduleTitle=JACC：依维莫司洗脱支架的长期安全性优于西罗莫司洗脱支架, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a316333963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990263, encodeId=229d199026358, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=Lancet：首次证实干细胞治疗的中长期安全性, objectType=article, longId=41358, objectId=9d414135854, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d414135854, replyNumber=0, likeNumber=59, createdTime=2015-03-17, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d414135854, moduleTitle=Lancet：首次证实干细胞治疗的中长期安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d414135854)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990262, encodeId=32b71990262bd, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=ARD：俾哥的斯治疗难治性痛风性关节炎的长期安全性稳定, objectType=article, longId=25161, objectId=b86725161fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b86725161fe, replyNumber=0, likeNumber=80, createdTime=2014-08-27, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b86725161fe, moduleTitle=ARD：俾哥的斯治疗难治性痛风性关节炎的长期安全性稳定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b86725161fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990261, encodeId=024d199026140, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=Circulation：老年患者生物瓣和机械瓣置换治疗的长期安全性和有效性, objectType=article, longId=17936, objectId=47dc1e93622, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47dc1e93622, replyNumber=0, likeNumber=61, createdTime=2014-02-19, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47dc1e93622, moduleTitle=Circulation：老年患者生物瓣和机械瓣置换治疗的长期安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47dc1e93622)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990260, encodeId=6e481990260d5, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=CREATE研究五年结果：EXCEL支架的长期安全性值得肯定, objectType=article, longId=6657, objectId=e021665e14, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e021665e14, replyNumber=0, likeNumber=104, createdTime=2012-06-29, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e021665e14, moduleTitle=CREATE研究五年结果：EXCEL支架的长期安全性值得肯定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e021665e14)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990259, encodeId=e1bd199025919, content=<a href='/topic/show?id=abc896996e1' target=_blank style='color:#2F92EE;'>#长期安全性#</a>, objectTitle=人体生物可降解冠脉支架长期安全性获证据, objectType=article, longId=5580, objectId=e92b5580bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92b5580bf, replyNumber=0, likeNumber=64, createdTime=2012-05-29, rootId=0, userName=fengxx, userId=65c7309, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92b5580bf, moduleTitle=人体生物可降解冠脉支架长期安全性获证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e92b5580bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

长期安全性

2020-05-29

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

J Natl Cancer Inst：HR+/HER2-乳腺癌哌柏西利联合内分泌治疗的长期安全性分析

2018-12-21

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性

2017-12-18

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

JACC：铂铬合金依维莫司洗脱支架用于冠脉疾病的长期安全性和疗效

2018-04-24

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性

2017-07-06

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

Diabetes Obes Metab：2型糖尿病患者采用替格列汀与canagliflozin联合治疗的长期安全性和疗效！

2017-09-11

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

Am J Kidney Dis：血液透析：蔗糖铁vs葡萄糖酸钠铁复合物的长期安全性

2018-03-26

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

J Am Acad Dermatol：crisaborole（2%乳膏）治疗轻度至中度特应性皮炎患者的长期安全性研究（AD-303）

2018-05-26

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

JACC：药物洗脱支架和金属裸支架的长期安全性

2016-03-01

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

JACC：依维莫司洗脱支架的长期安全性优于西罗莫司洗脱支架

2016-07-06

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

Lancet：首次证实干细胞治疗的中长期安全性

2015-03-17

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

ARD：俾哥的斯治疗难治性痛风性关节炎的长期安全性稳定

2014-08-27

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

Circulation：老年患者生物瓣和机械瓣置换治疗的长期安全性和有效性

2014-02-19

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

CREATE研究五年结果：EXCEL支架的长期安全性值得肯定

2012-06-29

fengxx (审核中...)

前往app查看评论内容

#长期安全性#

人体生物可降解冠脉支架长期安全性获证据

2012-05-29

科室
- - 订阅+
  - 更多科室
工具
服务